Flow cytometry has dramatically improved scientists’ ability to characterize individual cells from complex tissues. Its versatility and ease-of-use has led scientists to connect flow cytometry with technologies such as CRISPR screens and single-cell transcriptomics to answer intricate biological questions and improve existing treatments, such as stem cell therapies, for a variety of diseases. In this webinar, brought to you by BD Biosciences, Audrey Parent and Rasul Chaudhry will highlight how they leverage flow cytometry to improve stem cell therapies for diabetes and multiple sclerosis.
Topics to be covered
Speaker Information:
Audrey Parent, PhD
Assistant Professor
Diabetes Center
University of California, San Francisco
G. Rasul Chaudhry, PhD
Professor
Department of Biological Sciences
Co-director
Institute for Stem Cells and Regenerative Medicine
Oakland University
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy